Under treatment with WP1193 in combination with IL-6 they observed increased Insulin-like growth factor I (IGF1) signaling in both normoxic and hypoxic cells which confirmed the modulatory role of IGF1 in glioblastoma proliferation and migration [118]. The gene discussed is IGF1; the disease is glioblastoma.